Biogen BIIB Restructuring Reserve
Restructuring Reserve at other companies
Other financials
Where this comes from
Reported directly by Biogen in its filing.
Tagged under the XBRL concept us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1.
The source filing: Biogen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 6:36 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000875045-26-000075
In 2023 we initiated cost saving measures as part of our Fit for Growth program to reduce operating costs, while improving operating efficiency and effectiveness. The Fit for Growth program generated approximately $1.0 billion in gross operating expense savings by the end of 2025, some of which has been reinvested in various initiatives. The Fit for Growth program included net headcount reductions of approximately 1,400 employees and we incurred total restructuring charges of approximately $320.0 million by the end of 2025.
Item 1. Financial Statements (unaudited)
FAQ
- What is Biogen's restructuring reserve?
- Biogen (BIIB) reported restructuring reserve of $320M in Q3 2023.
- What does restructuring reserve mean?
- This represents the estimated liability for costs associated with formal restructuring plans, such as severance, facility closures, or asset impairments. It reflects management's commitment to operational efficiency and strategic realignment. These reserves are drawn down as the restructuring activities are executed.
Ask your AI about Biogen's restructuring reserve.
Connect your AI assistant and compare it to peers, right in your chat.
